Transcriptional profiles define drug refractory disease in myeloma

Transcriptional profiles define drug refractory disease in myeloma

Abstract Identifying biomarkers associated with disease progression and drug resistance are important for personalized care. We investigated the expression of 121 curated genes, related to immunomodulatory drugs (IMiDs) and proteasome inhibitors (PIs) responsiveness. We analyzed 28 human multiple my...

Full description

Bibliographic Details
Main Authors: Yuan Xiao Zhu, Laura A. Bruins, Xianfeng Chen, Chang‐Xin Shi, Cecilia Bonolo De Campos, Nathalie Meurice, Xuewei Wang, Greg J. Ahmann, Colleen A. Ramsower, Esteban Braggio, Lisa M. Rimsza, A. Keith Stewart
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:eJHaem
Subjects:
drug resistance
gene expression
myeloma
Online Access:https://doi.org/10.1002/jha2.455

Similar Items

Similar Items